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The fascia tissue, derived from the mesoderm, is distributed in all parts of the human
body. It consists of connective tissues and stem cells. The fascia tissue is also believed
to be a functional system, like the digestive system, in the human body, controlling
self-inspection, self-maintenance, support, and storage. In addition, much of the
research relevant to fascia tissue has focused on adipose-derived stem cells (ADSCs),
which mainly exist in adipose tissues. The aim of this review is to summarize the current
research on ADSCs, including a brief introduction of their biological characteristics, the
isolation and expansion methods, a conclusion on their multidifferentiation potential,
new clinical applications, and the therapeutic strategies for treating tumors.1. Introduction
The adipose-derived stem cells (ADSCs), first separated by
Zuk et al [1] from raw human lipoaspirates, originate from
mesoblasts and have multiproliferation capabilities. If
appropriately induced, the ADSCs can differentiate to lip-
ocytes, chondrocytes, osteoblasts, myoblasts, neurocytes,
etc. Although the bone marrow-derived stem cells (BMSCs)of Anatomy, Southern Medical U
, daijingxing@gmail.com
acopuncture Institute
3.03.004and the embryonic stem cells have therapeutic potentials
in tissue engineering and cell therapy, either they are hard
to harvest or their use is associated with ethical problems.
By contrast, the ADSCs are much easily isolated from the
adipose tissues, and their use is associated with almost no
ethical problems. Therefore, the ADSCs could be a prom-
ising source for future clinical cell therapy. Recent studies
have revealed that the ADSCs even influence the growth ofniversity, Guangzhou 510515, China.
130 Y. Ou et al.tumor cells, which means that the ADSCs may offer a novel
and attractive therapeutic strategy for treating tumors.
2. Biological characteristics
Even though no specific marker of the ADSCs has been
found yet, some markers can help to differentiate the
ADSCs. When cultured in vitro, apart from expressing
CD105, STRO-1, CD117, and CD166, which are common
markers for the stem cells, the ADSCs also express CD13,
CD29, CD44, CD49b, and CD49e. However, CD31, CD34,
CD45, CD133, and HLA2DR are seldom expressed. Although
some studies have proven that the ADSCs are morphologi-
cally similar to the BMSCs, the ADSCs express CD49, but not
CD106, whereas the BMSCs express CD106, but not CD49
[1e4].
Park and co-workers [5] found that CD44 expression
decreased remarkably as the passage number of the ADSCs
increased. Further experimentation revealed that when
treated with selective CDK2 and CDK1/CDC2 inhibitors,
low-passage ADSCs were similar to high-passage ADSCs in
morphology, differentiation potency, and the pattern of
stem cell transcriptional factor expression, which indi-
cated that cell-cycle regulators controlled the differenti-
ation potency of ADSCs. This result suggests that by
disturbing the expression of cell-cycle regulators, scientists
can control the extent of proliferation and differentiation
of ADSCs, which is significant for future clinical
applications.
3. Isolation and expansion
Since Zuk et al [1] first separated the ADSCs from the raw
human lipoaspirates, scientists have shown that the ADSCs
can be obtained from adipose tissues of humans, mice,
rabbits, pigs, etc. Although the ADSCs are harvested from
different animals, the isolation and culture methods are
mostly the same [6]. After the adipose tissues are ob-
tained, they are first washed with phosphate-buffered so-
lution (PBS) to remove impurities such as red blood cells.
They are then treated with 0.075% collagenase (type I) in
PBS for approximately 30 minutes at 37C with gentle
agitation. This is followed by addition of Dulbecco’s
modified Eagle’s medium with 10% fetal bovine serum to
inactivate the collagenase. After centrifuging at low speed
for 10 minutes, a 100-mm mesh filter is used to remove
debris, after which the filtrate is centrifuged again and
placed in a conventional tissue culture medium (37C, 5%
CO2). The tissue culture medium is changed once in every 3
days [1].
Although the aforementioned method is acknowledged
as the most typical one, scientists are still searching for
factors that influence the isolation and culture of the
ADSCs. Recent studies revealed that age was the most
important factor and that gender, sampled specimen,
concentration of collagenase, and time of collagenolysis
could also affect the isolation and culture of the ADSCs. In
fact, results of a previous study showed that a 4-week-old
female Sprague-Dawley rat was more likely to produce the
ADSCs with good quality and that the most appropriate
concentration of collagenase was 0.1% [6].4. Multidifferentiation potential
As mentioned previously, no specific marker of the ADSCs
has been found yet. Therefore, the ADSCs cannot be pre-
cisely identified only using surface markers. Inducement,
which aims to prove their multipotential differentiation
ability, is also needed. Through inducement, the ADSCs can
differentiate to lipocytes, chondrocytes, osteoblasts,
myoblasts, neurocytes, etc. [4]. The commonly used
inducement methods are shown in Table 1 [7e13].
Some traditional Chinese medicines are believed to have
positive effects on the proliferation and differentiation of
the ADSCs. For example, a polysaccharide distilled from
Rehmannia glutinosa has been proven to protect the ADSCs
from injury caused by H2O2 exposure and to increase the
proliferation rate of the ADSCs without interrupting the
phenotype. However, when 5-azacytidine (5-aza) was
added, the cardiac myogenesis rate of the R. glutinosa
polysaccharide group was higher [14].
5. Experiments for further clinical applications
Because the multidifferentiation potential of the ADSCs has
been demonstrated, more and more emphasis is being put
on their promising clinical applications, especially their
ability to regenerate tissues in cases of medical problems
such as bone injuries, cardiac infarctions, and neural in-
juries (i.e., they can initiate osteogenesis, chondrogenesis,
cardiac myogenesis, angiogenesis, and neurogenesis).
Yang et al and Zhang et al [15,16] proved that the ADSCs
were compatible with the xenogeneic bone scaffold. Even
more excitingly, scientists have found that without
inducement, the ADSCs have the ability to repair defects
and damage to full-thickness hyaline cartilage [17,18] by
improving osteogenesis and the microstructure of vascular
deprivation-induced osteonecrotic tissue [19].
As shown in Table 1, the ADSCs were able to differen-
tiate into myocardial cells. In addition, cardiac myogenesis
was successful not only in vitro but also in vivo. When 5-
aza-induced ADSCs were included in the myocardial
infarction model, the scale of the infarction decreased, and
the ADSCs were shown to differentiate into myocardial
cells, as well as endothelial cells. Those cells secreted
vascular endothelial growth factor (VEGF), which increased
the density of blood vessels at the transplantation site [20].
However, the ADSC transplantation therapy is not
without its problem. Like most stem cells, the ADSCs have a
poor survival rate after implantation [21]. Thus, scientists
are looking for newer ways to enhance the efficacy of
cellular cardiomyoplasty, such as the use of transplanted
ADSCs combined with hemeoxygenase-1 transduction [22].
The evidence showing the above also revealed that the
ADSCs had a more promising future in curing cardiac dis-
eases than BMSCs and embryonic stem cells. Although em-
bryonic stem cells were totipotent, their use was restricted
by ethical problems. The BMSCs not only have sampling
difficulty, but also fail to be induced into myocardial cells.
By contrast, the ADSCs are easy to harvest, are not asso-
ciated with ethical problems, and can be easily induced
into myocardial cells. Thus, the ADSCs may be the seed
cells for curing cardiac diseases [23]. However, current
Table 1 Commonly used methods for inducing ADSCs.
Differentiation direction Culture condition Results
Adipogenesis DMEM, 10% FBS, 0.5 mmol/L
3-isobutyl-1-methylxanthine,
1 mmol/L dexamethasone, 10 mmol/L
insulin, 200 mmol/L indomethacin
(3 days)
Shape: polygonal Lipid droplets appeared;Oil
red O staining: positive;Fatty acid-binding proteins:
lipoprotein, lipase, peroxisome; Proliferator-activated
receptor: detected
Osteogenesis DMEM, 10% FBS, 0.1 mmol/L
dexamethasone, 50 mg/L vitamin C,
10 mmol/L b-glycerophosphate
(10 days)
Shape: Long spindle to round, nodular; Alizarin red (AR)
staining: positive; Expressions of the following genes and
proteins related to osteogenesis: alkaline phosphatase,
collagenase (type I), osteopontin, osteonectin, calcitonin,
sialoprotein, bone morphogenetic proteins II and IV, bone
morphogenetic protein receptors I and II
Chondrogenesis DMEM, 10% FBS, 6.25 mg/L insulin,
TGF-b, 10 mg/L, vitamin C, 50
mmol/L(2e4 weeks)
Chondroitin sulfate, hyaluronic acid, keratan sulfate,
type II and IV collagen fibers
Skeletal
myogenesis
DMEM, 10% FBS, 50 mm hydrocortisone,
1% antibiotic/antimycotic
Cells integrated to multinucleated myotubes;
Muscle-derived determinants, myosin and myosin
light-chain kinase are detected
Cardiac
myogenesis
DMEM, 10% FBS, 5-azacytidine Cardiac-specific cardiac troponin I (cTNI) expression:
positive; Cardiac b-myosin heavy chain (cardiac b-MHC)
gene expression: positive
Neurogenesis DMEM, 10% FBS, 5e10 mmol
b-mercaptoethanol
Neuron-specific markers: NF-M, NSE, MAP2, and GFAP
Angiogenesis DMEM, 10% FBS, VEGF or bFGF CD31, CD34, acetylated low-density lipoprotein (DiI-ac-LDL)
phagocytosis combined with FITC lectin
ADSCZ adipose-derived stem cells; bFGFZ basic fibroblast growth factor; DMEMZ Dulbecco’s modified Eagle’s medium; FBSZ fetal
calf serum; FITC Z fluorescein isothiocyanate; GFAP Z glial fibrillary acidic protein; MAP2 Z microtubule-associated protein 2; NF-
MZ neurofilament-M; NSEZ neuron-specific enolase; TGFZ transforming growth factor-b; VEGFZ vascular endothelial growth factor.
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ADSCs will work the same way in humans is still to be seen.
Even if scientists succeed in transplanting the ADSCs into
human body, they might not be capable of establishing
connections with local myocardial cells. What is more, the
new-born myocardial cells may cause arrhythmia. All these
issues are puzzling and remain to be addressed.
If cultured with b-mercaptoethanol, the ADSCs tend to
be shaped like neuronal cells, and early markers of
neuronal lineage, such as nestin, neuron-specific enolase,
and neuronal nuclei are detected [24]. However, markers of
mature neuronal cells (such as neurons, oligodendroglia,
and astrocytes) have not yet been found during long-term
culturing. This phenomenon may result from a restriction
imposed by the medium. Recently, the ADSCs have been
shown to help repair peripheral nerve injury [25,26].
Transplantation of the ADSCs promotes functional recovery
in animal models of peripheral nerve injury. Moreover, the
ADSCs can also be induced into Schwann-like cells, holding
promise for treating demyelinating diseases [27]. Although
the mechanisms are yet to be illustrated, nowadays scien-
tists commonly consider paracrine secretions to be the
main mechanism.
VEGF or basic fibroblast growth factor (bFGF) has been
shown to have the ability to induce ADSCs to become
vascular endothelial cells in vitro [26,28]. Interestingly,
increases in VEGF secretion and the number of vessels are
very common in neuronal and cardiac studies concerningthe ADSCs. Some scientists even found that transplantation
of ADSCs promoted revascularization in cerebral ischemic
rats partly by promoting the expression of transforming
growth factor-b1 (TGF-b1) in the brain [29]. In addition,
bFGF and VEGF played important roles, and the trans-
plantation of the ADSCs promoted revascularization in ce-
rebral ischemic rats partly by enhancing bFGF and VEGF
synthesis in the brain [30]. In a study on the regeneration of
radiation-damaged salivary glands, the ADSCs partly
restored salivary gland function, which had been lost due to
the irradiation; moreover, the number of blood vessels was
obviously increased, which was thought to be related to the
paracrine effects of bFGF and VEGF [31].
All this evidence has revealed that the ADSCs tend to
differentiate into vascular endothelial cells or help revas-
cularization through paracrine secretion when treating
most kinds of ischemic or necrotic diseases. By revascu-
larization, the lesion fields receive more nutrition, which
provides the sources needed for tissues to recover. How-
ever, the reasons that the ADSCs can act in this way are still
unknown, even though one may speculate that one reason
might be a change in the microenvironment around the
lesion, which stimulates the secretion of factors such as
VEGF and TGF-b, thus leading to angiogenesis of the ADSCs
[32e34]. Moreover, those activated ADSCs in turn stimulate
the secretions of VEGF and TGF-b.
The ADSCs are capable of secreting large numbers of
angiogenesis-related cytokines [21], among which VEGF and
132 Y. Ou et al.TGF-b are the two most commonly seen factors in most
studies. TGF-b inhibits inflammation, which might partly
explain the compatibility with the xenogeneic bone scaf-
fold. TGF-b also promotes tissue maintenance by enhancing
the growth of fibroblasts, skeletogenous cells, and Schwann
cells. That is why the paracrine function is such an impor-
tant character of the ADSCs, making them one of the most
promising seed cells.
6. Tumor-related experimental progress
Obesity is recognized to be involved in the higher in-
cidences of many diseases, such as prostate cancer and
hepatic cancer, which suggests that the ADSCs may have a
suspicious character. Scientists have surprisingly observed
that prostate cancer cells recruit ADSCs, which help tumor
growth by increasing tumor vascularity and which is medi-
ated by FGF2 [35]. Further studies discovered that the
ADSCs shortened or even eliminated the latent period of
tumor cells so as to promote the growth of melanomas [36].
In addition, exosomes, which are released from tumor cells,
tended to induce the myofibroblastic phenotype in the
ADSCs by activating an intracellular signaling pathway [37].
Despite this bad news, the ADSCs have also been found
to inhibit the growth of tumors in several ways. For
example, the ADSCs have an amazing migratory capacity
toward malignant gliomas [38]. This ability makes the
ADSCs a good therapeutic delivery vehicle for the oncolytic
myxoma virus (vMyxgfp), which has oncolytic properties
against human brain tumor cells both in vitro and in vivo.
However, the therapeutic effect of the myxoma virus is
limited because it is only effective when directly injected
into the tumor bed, which is unrealistic when treating brain
cancer. Even worse, the life span of the virus in vivo is too
short to have an ideal therapeutic effect. Research has
suggested that the ADSCs not only serve as a vehicle for
myxoma virus transport but also improve myxoma virus
replication. Therefore, some scientists have concluded that
the ADSCs may shed some light on ways to cure malignant
gliomas. Moreover, an ADSC-conditioned medium has even
been reported to inhibit the growth of pancreatic ductal
adenocarcinomas strongly and induce tumor cell death by
altering the progression of cell cycle. The mechanism might
be due to the decrease in CDK4 and Cyclin D1, which in turn
inhibits the phosphorylation of the Rb gene [39].
According to the present results, no one can draw a clear
conclusion on how the ADSCs affect tumor cells. Facing
different kinds of tumors, the ADSCs either inhibit or pro-
mote tumor growth directly or sometimes indirectly. How-
ever, VEGF and FGF have both been mentioned to play roles
in promoting tumor growth, and increases in the numbers of
blood vessels have been discovered. Both of these may be
important factors in promoting tumor growth and should
receive more attention in future clinical experiments and
applications.
7. Summary
To summarize, the ADSCs have certainly been a subject of
controversy worldwide. Recently, many conclusions and
hypotheses have been made based on the results of manyresearch projects. Dozens of surface markers have been
found, but no specific marker of the ADSCs has yet been
identified, and although general culture methods have been
quite successful, scientists are still working to develop
better methods.
The ADSCs have many excellent characteristics, such as
easy obtention, fewer rejections, and multidifferentiation
potential, which give ADSCs a promising future in tissue
engineering. Furthermore, the ADSCs help with antiaging
and antifatigue as well as with revascularization and
regeneration of tissues damaged by many different kinds of
medical problems, such as arthritis, neuronal injuries, and
cardiac infarction. However, they also facilitate tumor
growth, partly through revascularization. Whether the ef-
fect is positive or negative, it is reported to be related to
factors that are produced through the paracrine functions
of the ADSCs, such as VEGF, FGFs, and TGF-b. Even more
important, problems such as establishing a connection with
local cells remain to be solved. All the successes and
problems suggest that more efforts are needed if the ADSCs
are to be put into clinical use.
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